Tellus Therapeutics
Cell & Gene Therapy · Biotechnology
$18Mtotal raised · 4 rounds on record
$16Mlatest round · Venture round · Nov 2022 · 3 yr ago
1backers · Xontogeny
$697kgrants · 1 grant · CORDIS
Overview
Transforming Care Within and Beyond the NICU. Tellus Therapeutics was founded on a singular mission: to bring hope and healing to the most vulnerable patients – premature infants facing life-altering brain and gut injuries with no treatment options.
Funding and backers
Total raised
$18M
4 rounds on record
Latest round
$16M
Venture round · Nov 2022 · 3 yr ago
Team
4
US Form 5500 (plan participants) · Dec 2025 · -20% in a year
Grants
$697k
1 grant · CORDIS
Backers
1
Xontogeny
The money's age
Long since its last round
47 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 17, 2022
Raised a round Venture round $16M · SEC Form D
May 10, 2021
Raised a round Venture round $2M · SEC Form D
Sep 30, 2020
Won a grant $697k · CORDIS
Jan 21, 2019
Took on debt financing $75k · SEC Form D
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 5%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2022 | $16M | — | SEC Form D |
| Venture round | May 2021 | $2M | — | SEC Form D |
| Grant | Sep 2020 | $697k | — | CORDIS |
| Debt Financing | Jan 2019 | $75k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Tellus Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jason KarlicExecutive Officer, DirectorSEC Form D
Eric BennerExecutive Officer, DirectorSEC Form D
Jason KralicExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune…
Immuneel is advancing access to breakthrough cancer therapies in India, for India and the world.. Cell, gene, and immunotherapies are…
Novel Immunotherapies For Vulnerable Patients. At Belyntic, we are developing new therapies that harness the power of the patients' own…
Claris Bio is dedicated to advancing transformative therapies for sight-threatening conditions where limited or no treatment options exist.
Delivering the next generation of automated cell and gene therapy manufacturing platforms to bring precision medicine to patients.
People
Jason Karlic
Executive Officer, Director
Eric Benner
Executive Officer, Director
Jason Kralic
Executive Officer, Director
Alex Ruckdaeschel
Director
Fred Callori
Director
Chris Garabedian
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
XontogenyVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hillsborough
United States
HQ
50-200 est. staff